CCK-4

Suppliers

Names

[ CAS No. ]:
1947-37-1

[ Name ]:
CCK-4

[Synonym ]:
Cholecystokinin Fragment 30-33 Amide
cholecystokinin-4
H-Trp-Met-Asp-Phe-NH2
L-Phenylalaninamide,L-tryptophyl-L-methionyl-L-a-aspartyl
cholecystokinin tetrapeptide
Cholecystokinin fragment 30-33 amide
Cholecystokinin C-terminal tetrapeptide

Chemical & Physical Properties

[ Density]:
1.341g/cm3

[ Boiling Point ]:
1159.2ºC at 760mmHg

[ Molecular Formula ]:
C29H36N6O6S

[ Molecular Weight ]:
596.70

[ Flash Point ]:
654.8ºC

[ Exact Mass ]:
730.27800

[ PSA ]:
247.11000

[ LogP ]:
4.67950

[ Vapour Pressure ]:
0mmHg at 25°C

[ Index of Refraction ]:
1.643

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
SQ7310000
CHEMICAL NAME :
L-Phenylalaninamide, N-((phenylmethoxy)carbonyl)-L-tryptophyl-L-methionyl- L-aspartyl-
CAS REGISTRY NUMBER :
1947-37-1
LAST UPDATED :
199806
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C37-H42-N6-O8-S

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,816,1995
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,816,1995
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,121,1969
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>2 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,121,1969
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
>1 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,121,1969
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Mammal - dog
DOSE/DURATION :
>100 mg/kg
TOXIC EFFECTS :
Behavioral - excitement Gastrointestinal - hypermotility, diarrhea Gastrointestinal - nausea or vomiting
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,121,1969
TYPE OF TEST :
LD - Lethal dose
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
>5 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,121,1969 ** OTHER MULTIPLE DOSE TOXICITY DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
46800 mg/kg/26W-I
TOXIC EFFECTS :
Biochemical - Enzyme inhibition, induction, or change in blood or tissue levels - transaminases
REFERENCE :
OYYAA2 Oyo Yakuri. Pharmacometrics. (Oyo Yakuri Kenkyukai, CPO Box 180, Sendai 980-91, Japan) V.1- 1967- Volume(issue)/page/year: 3,121,1969

Safety Information

[ Personal Protective Equipment ]:
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter

[ RIDADR ]:
NONH for all modes of transport

Articles

Overexpression of the Promigratory and Prometastatic PTK7 Receptor Is Associated with an Adverse Clinical Outcome in Colorectal Cancer.

PLoS ONE 10 , e0123768, (2015)

Biomarkers and novel therapeutic targets are urgently needed in colorectal cancer (CRC). The pseudo tyrosine kinase receptor 7 (PTK7) is involved in planar cell polarity and it is deregulated in vario...

CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells.

J. Mol. Neurosci. 56 , 663-72, (2015)

Cholecystokinin (CCK) receptors are G-protein coupled receptors (GPCR) which are present on lung cancer cells. CCK-8 stimulates the proliferation of lung cancer cells, whereas the CCK2R receptor antag...

Synthesis, characterization and in vitro evaluation of new oxorhenium- and oxotechnetium-CCK4 derivatives as molecular imaging agents for CCK2-receptor targeting.

Eur. J. Med. Chem. 45(2) , 423-9, (2010)

The goal of this study is to design new (99m)Tc-radiolabelled shortened CCK derivatives that might be suitable for the molecular imaging of cholecystokinin-2 receptors (CCK2-R), these receptors being ...


More Articles


Related Compounds

  • CCK-4
  • Boc-CCK-4
  • CCK-4 HYDROCHLORIDE
  • (Asn3)-CCK-4, (Asn3)-Gastrin Tetrapeptide
  • 2,4,6,7-tetramethyl-2,6,7-triaza-1-phosphabicyclo[2.2.2]octane
  • 1,4-bis(5-bromothiophen-2-yl)butane-1,4-dione
  • 2-(1,3,4-Thiadiazol-2-yl)ethan-1-ol
  • 5,6-Difluorobenzo[B]thiophene-3-boronic acid pinacol ester
  • 1,1,1-Trifluoro-3-(methylamino)propan-2-one
  • (1R,2R)-2-Methylcyclopropan-1-ol
  • 5-Amino-6-ethoxypyrazine-2-boronic acid pinacol ester
  • N,N-dimethyl-3-azaspiro[5.5]undecan-9-amine
  • 5-Amino-6-morpholinopyrazine-2-boronic acid pinacol ester
  • 5,6-Diethoxypyridine-3-boronic acid pinacol ester
  • 3-Bromo-5-fluoro-4-methoxybenzyl bromide
  • 3-Methyl-2,3-dihydro-1H-Pyrrolo[2,3-b]pyridine-5-boronic acid pinacol ester
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.